文献速递儿科与产科急症心脑血管急症重症综合管理与镇静镇痛

儿童心脏骤停治疗性低温试验中3个月与12个月神经行为结局的关系

Relationships between three and twelve month outcomes in children enrolled in the therapeutic hypothermia after pediatric cardiac arrest trials.
PubMed 文献 · Resuscitation · 2019-03-26
一句话结论在THAPCA试验的儿童心脏骤停幸存者中,3个月VABS-II和PCPC对12个月良好结局预测敏感性≥70%,12个月诊断准确率≥80%,作者认为未来试验可考虑纳入3个月神经行为结局指标。

该研究比较THAPCA-OH和THAPCA-IH两项试验中儿童心脏骤停后3个月与12个月神经行为结局。研究对象为2009-2015年纳入的2天至<18岁儿童,干预为两种目标温度管理(低温32.0-34.0°C;常温36.0-37.5°C)。222例合格幸存者中204例有3个月和12个月VABS-II和PCPC数据(THAPCA-OH 82例,THAPCA-IH 122例)。THAPCA-OH较THAPCA-IH骤停前残疾显著更少、12个月骤停后损伤显著更重;3个月与12个月VABS-II评分相关性在THAPCA-OH为r=0.95、THAPCA-IH为r=0.72,THAPCA-IH较低(p≤0.001)。两队列3个月VABS-II和PCPC分类结局预测12个月良好VABS-II结局敏感性≥70%,但THAPCA-IH特异性(68-89%)低于THAPCA-OH(≥95%);两队列12个月诊断准确率均≥80%。作者认为未来纳入相似队列的儿童心脏骤停临床试验可考虑整合3个月神经行为结局指标。

要点

  • 在THAPCA-OH和THAPCA-IH幸存者中,3个月VABS-II和PCPC分类结局预测12个月良好VABS-II结局的敏感性均≥70%。
  • THAPCA-IH的3个月预测特异性为68-89%,低于THAPCA-OH的≥95%,提示住院骤停后早期结局预测需谨慎。
  • 3个月与12个月VABS-II评分相关性在THAPCA-OH为r=0.95、THAPCA-IH为r=0.72,THAPCA-IH相关性较低(p≤0.001)。
  • 两队列12个月VABS-II和PCPC诊断准确率均≥80%,作者认为未来相似队列试验可考虑纳入3个月神经行为结局指标。
  • THAPCA-OH较THAPCA-IH骤停前残疾显著更少、12个月骤停后损伤显著更重(基于VABS-II和PCPC)。

适用人群与场景

  • THAPCA-OH和THAPCA-IH试验纳入的儿童,年龄2天至<18岁,2009-2015年入组。
  • 主要结局分析纳入无显著骤停前神经发育缺陷的儿童。
  • 3个月和12个月VABS-II和PCPC数据可获得的222例合格幸存者中204例(THAPCA-OH 82例,THAPCA-IH 122例)。

诊断标准与关键阈值

  • 12个月良好结局定义为幸存者VABS-II≥70。
  • VABS-II人群均值=100,标准差=15。
  • 神经行为结局采用Vineland Adaptive Behavior Scales第二版(VABS-II)和儿科脑功能分类(PCPC)量表评估。

处置流程与药物剂量

  • THAPCA试验评估两种目标温度管理干预:低温32.0-34.0°C;常温36.0-37.5°C。

研究设计与关键结果

  • 研究类型为对THAPCA-OH和THAPCA-IH试验数据的比较分析;204例幸存者有3个月和12个月VABS-II和PCPC数据(THAPCA-OH 82例,THAPCA-IH 122例)。
  • THAPCA-OH较THAPCA-IH骤停前残疾显著更少、12个月骤停后损伤显著更重(基于VABS-II和PCPC)。
  • 3个月与12个月VABS-II评分相关性:THAPCA-OH r=0.95,THAPCA-IH r=0.72,THAPCA-IH较低(p≤0.001)。
  • 在骤停时<1岁的儿童中,两时间点间相关性较低但仍显著(p<0.001)。
  • 两队列3个月VABS-II和PCPC分类结局预测12个月良好VABS-II结局的敏感性≥70%;特异性THAPCA-IH为68-89%,THAPCA-OH≥95%。
  • 两队列12个月VABS-II和PCPC诊断准确率均≥80%。

证据类型、等级与局限

  • 证据类型:对THAPCA-OH和THAPCA-IH两项试验数据的比较分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在纳入相似队列的未来儿童心脏骤停临床试验中,可考虑整合3个月神经行为结局测量。
  • 在THAPCA-IH幸存者中,3个月VABS-II和PCPC分类结局预测12个月良好VABS-II结局的特异性为68-89%,低于THAPCA-OH的≥95%。

指南或共识出处

  • THAPCA-OH和THAPCA-IH试验(Therapeutic Hypothermia After Pediatric Cardiac Arrest Out-Of-Hospital and In-Hospital trials)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM: To inform design aspects of future trials by comparing 3 and 12-month neurobehavioural outcomes in children enrolled in Therapeutic Hypothermia After Pediatric Cardiac Arrest Out-Of-Hospital and In-Hospital (THAPCA-OH, THAPCA-IH) trials.

METHODS: The THAPCA trials evaluated two targeted temperature management interventions (hypothermia, 32.0-34.0 °C; normothermia, 36.0-37.5 °C). Children, aged 2 days to <18 years, were enrolled from 2009-2015. Three and 12-month post-cardiac arrest (CA) outcomes included the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) (population mean = 100, SD = 15) and the pediatric cerebral performance category (PCPC) scale. Children without significant pre-existing neurodevelopmental deficits were included in primary outcome analyses. Among survivors, favorable 12-month outcome was defined as VABS-II ≥ 70.

RESULTS: VABS-II and PCPC were available at 3 and 12 months in 204 of 222 eligible survivors (THAPCA-OH, n = 82; THAPCA-IH, n = 122). Relative to THAPCA-IH, THAPCA-OH had significantly less pre-CA disability and significantly greater 12-month CA impairment, based on both VABS-II and PCPC. Correlations between 3 and 12-month VABS-II scores were strong for THAPCA-OH (r = 0.95) and THAPCA-IH (r = 0.72), and lower (p ≤ 0.001) in THAPCA-IH. Between time-points correlations were lower, but still significant in children <1 year at CA (p < 0.001). In both cohorts, 3-month VABS-II and PCPC categorical outcomes had high sensitivity (≥70%) for predicting favorable 12-month VABS-II outcomes, but specificity was lower for THAPCA-IH (68-89%) relative to THAPCA-OH (≥95%). Overall, 12-month diagnostic accuracy was ≥80% for both VABS-II and PCPC in both cohorts.

CONCLUSIONS: In future paediatric cardiac arrest clinical trials that enroll similar cohorts, integration of 3-month neurobehavioral outcome measures should be considered.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Slomine BS, Silverstein FS, Page K, et al. Relationships between three and twelve month outcomes in children enrolled in the therapeutic hypothermia after pediatric cardiac arrest trials. Resuscitation. 2019. PMID: 30922934. doi:10.1016/j.resuscitation.2019.03.020

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。